- Home
- PENN vs HCM Comparison
PENN vs HCM Comparison
Compare PENN & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PENN
- HCM
- Stock Information
- Founded
- PENN 1972
- HCM 2000
- Country
- PENN United States
- HCM Hong Kong
- Employees
- PENN N/A
- HCM N/A
- Industry
- PENN Hotels/Resorts
- HCM Biotechnology: Pharmaceutical Preparations
- Sector
- PENN Consumer Discretionary
- HCM Health Care
- Exchange
- PENN Nasdaq
- HCM Nasdaq
- Market Cap
- PENN 2.8B
- HCM 2.6B
- IPO Year
- PENN 1994
- HCM N/A
- Fundamental
- Price
- PENN $17.00
- HCM $16.39
- Analyst Decision
- PENN Buy
- HCM Sell
- Analyst Count
- PENN 19
- HCM 1
- Target Price
- PENN $22.89
- HCM $13.75
- AVG Volume (30 Days)
- PENN 3.2M
- HCM 55.6K
- Earning Date
- PENN 11-06-2025
- HCM 08-07-2025
- Dividend Yield
- PENN N/A
- HCM N/A
- EPS Growth
- PENN N/A
- HCM N/A
- EPS
- PENN N/A
- HCM 0.53
- Revenue
- PENN $6,745,700,000.00
- HCM $602,197,000.00
- Revenue This Year
- PENN $8.37
- HCM N/A
- Revenue Next Year
- PENN $5.54
- HCM $15.49
- P/E Ratio
- PENN N/A
- HCM $5.85
- Revenue Growth
- PENN 7.33
- HCM N/A
- 52 Week Low
- PENN $13.25
- HCM $11.51
- 52 Week High
- PENN $23.08
- HCM $21.50
- Technical
- Relative Strength Index (RSI)
- PENN 34.95
- HCM 52.28
- Support Level
- PENN $18.89
- HCM $16.00
- Resistance Level
- PENN $19.43
- HCM $16.39
- Average True Range (ATR)
- PENN 0.48
- HCM 0.28
- MACD
- PENN -0.22
- HCM 0.01
- Stochastic Oscillator
- PENN 0.00
- HCM 43.68
About PENN PENN Entertainment Inc.
Penn Entertainment's origins date back to its 1972 racetrack opening in Pennsylvania. Today, Penn operates 43 properties across 20 states and 12 brands, including Hollywood Casino and Ameristar. Land-based casinos represented 85% of total sales in 2024; 15% was from the interactive segment, which includes sports, iGaming, and media revenue. The retail portfolio generates mid-30s EBITDAR margins and helps position the company to obtain licenses for the digital wagering markets. Additionally, Penn's media assets, theScore and ESPN (starting with its partnership launch in November 2023), provide access to sports betting/iGaming technology and clientele, helping it form a leading digital position.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.